Surgery Websites
Breast Care Surgery »  Faculty »  Breast Care Surgeons »  Michael D. Alvarado, M.D.
Michael D. Alvarado, M.D.

Michael D. Alvarado, M.D.

  • Professor of Surgery
  • Division of Surgical Oncology
  • Director, Breast Surgery Oncology Fellowship

Contact Information

Academic Office
415-353-7908
415-353 9571 - Fax
michael.alvarado@ucsf.edu

Open Popup

Education

  • 1985-89, Arizona State University, BS, Chemistry
  • 1990-92, University of Arizona, Physical Chemistry, MA
  • 1994-98, Dartmouth Medical School, MD

Residencies

  • 1998-04, Surgical Residency, Dartmouth Hitchcock Medical Center
  • 1998-03, Surgical Residency, Dartmouth Medical School
  • 2003-04, Chief Resident, Surgery, Dartmouth Medical School

Fellowships

  • 2004-06, Surgical Oncology, H. Lee Moffitt Cancer Center

Board Certifications

  • 2005, American Board of Surgery

Program Affiliations

  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Melanoma Center
  • Carol Franc Buck Breast Care Center

Clinical Expertise

Research Interests

  • Investigation of blood-based and molecular markers to improve breast cancer screening
  • Sentinel Lymph Node Biopsy

Website Links

Biography

Michael Alvarado, M.D. is a Professor of Surgery and member of the breast care and melanoma programs. Dr. Alvarado received his undergraduate degree from Arizona State University, his master's degree in chemistry from the University of Arizona and his medical degree from Dartmouth Medical School.

After completing his residency at Dartmouth-Hitchcock Medical Center, he completed his surgical oncology fellowship at the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida. There he conducted research in the Department of Interdisciplinary Oncology on comparative gene expression profiling of stage III colon cancer and sentinel lymph node biopsy for patients undergoing mastectomy.

Dr. Alvarado plays an integral role in the world-renowned multidisciplinary breast care team at the Breast Care Center in the UCSF Helen Diller Family Comprehensive Cancer Center. He is also Director of the Breast Surgical Oncology Fellowship Program and is intimately involved in the training of breast cancer surgeons of the future. 

Dr. Alvarado performs melanoma surgery including sentinel lymph node biopsy at the UCSF Melanoma Center, a multidisciplinary program consisting of melanoma surgeons, dermatologists, medical oncologists, dermatopathologist and head and neck surgeon.

Highly respected by his peers, Dr. Alvarado was named to the list of U.S. News "Top Doctors," which denotes the top 10% of physicians within a region practicing a given specialty. Dr. Alvarado is certified by the American Board of Surgery, member of the Society of Surgical Oncology and member of the American College of Surgeons.  

  

 

 

 

 

Clinical Trials

Data provided by UCSF Profiles, powered by CTSI

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 85
Data provided by UCSF Profiles, powered by CTSI
  1. Barnes LL, Foster R, Mukhtar RA, Esserman LJ, Ewing C, Alvarado M, Wong J, Piper M. Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes. Plast Reconstr Surg Glob Open. 2023 Jan; 11(1):e4767. View in PubMed
  2. Onal C, Sezen D, Oymak E, B?l?kbasi Y, Spratt DE, Ward MC, Fasola CE, White RL, Bentzen SM, Khan AJ, Vicini F, Shah C, Vaidya JS, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, Williams NR, Brew-Graves C, Bernstein M, Holmes D, Vinante L, Pigorsch S, Lundgren S, Uhl V, Joseph D, Tobias JS. In Regard to Hammer et al. Int J Radiat Oncol Biol Phys. 2023 Jan 01; 115(1):253-254. View in PubMed
  3. Leung S. In Reply to Ward et al. Int J Radiat Oncol Biol Phys. 2023 Jan 01; 115(1):256-259. View in PubMed
  4. Vaidya JS, Bulsara M, Wenz F, Sperk E, Massarut S, Alvarado M, Williams NR, Brew-Graves C, Bernstein M, Holmes D, Vinante L, Pigorsch S, Lundgren S, Uhl V, Joseph D, Tobias JS, TARGIT-A authors. The TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):77-82. View in PubMed
  5. Clark AS, Yau C, Wolf DM, Petricoin EF, van 't Veer LJ, Yee D, Moulder SL, Wallace AM, Chien AJ, Isaacs C, Boughey JC, Albain KS, Kemmer K, Haley BB, Han HS, Forero-Torres A, Elias A, Lang JE, Ellis ED, Yung R, Tripathy D, Nanda R, Wulfkuhle JD, Brown-Swigart L, Gallagher RI, Helsten T, Roesch E, Ewing CA, Alvarado M, Crane EP, Buxton M, Clennell JL, Paoloni M, Asare SM, Wilson A, Hirst GL, Singhrao R, Steeg K, Asare A, Matthews JB, Berry S, Sanil A, Melisko M, Perlmutter J, Rugo HS, Schwab RB, Symmans WF, Hylton NM, Berry DA, Esserman LJ, DeMichele AM. Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial. Nat Commun. 2021 11 05; 12(1):6428. View in PubMed
  6. View All Publications

 

 
Site Directory
    X